Brief: Alterity Therapeutics Says FY Revenue For Ordinary Activities Down 87.9% To A$2,504
31/08/2022 09:21
Aug 31 (Reuters) - Alterity Therapeutics Ltd ATH.AX :
* FY REVENUE FOR ORDINARY ACTIVITIES DOWN 87.9% TO A$2,504
* NET LOSS AFTER TAX FOR YEAR ATTRIBUTABLE A$12.8 MILLION
Further company coverage: ATH.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alterity Therapeutics
See all newsBrief: Alterity Therapeutics Achieves Alignment With U.S. FDA On Pivotal Phase 3 Program For Ath434 In Multiple System Atrophy
Brief: Alterity Therapeutics Receives Positive FDA Feedback On Ath434 Phase 3 Program
Brief: Alterity Therapeutics Says Julian Barbaczy Appointed Non-Exec Chair
Brief: Alterity Therapeutics Raises A$20.0 Million In Strategic Placement
Brief: Alterity Therapeutics Ltd Raises A$20 Million In Capital